US Stock MarketDetailed Quotes

ARWR Arrowhead Pharmaceuticals

Watchlist
  • 22.330
  • -0.280-1.24%
Close Apr 19 16:00 ET
  • 22.330
  • +0.000+0.00%
Post 17:53 ET
2.77BMarket Cap-8061P/E (TTM)

About Arrowhead Pharmaceuticals Company

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Company Profile

SymbolARWR
Company NameArrowhead Pharmaceuticals
Listing DateJun 16, 1993
Issue Price3.60
Founded1989
CEODr. Christopher Anzalone,PhD
MarketNASDAQ
Employees525
Securities TypeOrdinary Shares
Fiscal Year Ends09-30
Address177 East Colorado Boulevard,Suite 700
CityPasadena
ProvinceCalifornia
CountryUnited States of America
Zip Code91105
Phone1-626-304-3400
Websitehttp://www.arrowheadpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Christopher Anzalone,PhD
  • Director, Chief Executive Officer and President
  • 9.92M
  • Patrick C. O'Brien
  • Chief Operating Officer, General Counsel, Chief Compliance Officer and Corporate Secretary
  • 3.31M
  • Tracie Oliver
  • Chief Commercial Officer
  • --
  • Kenneth Myszkowski
  • Chief Financial Officer and Principal Accounting Officer
  • 3.12M
  • Dr. Douglass Given, PhD
  • Chairman of the Board
  • 474.60K
  • William D. Waddill
  • Independent Director
  • 469.60K
  • Victoria Vakiener
  • Independent Director
  • 452.10K
  • Dr. Adeoye Olukotun, M.D.,M.P.H.
  • Independent Director
  • 459.60K
  • Dr. Mauro Ferrari
  • Independent Director
  • 459.60K
  • Dr. Hongbo Lu, PhD
  • Independent Director
  • --
  • Dr. Michael S. Perry, PhD
  • Independent Director
  • 459.60K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg